AI assistant
KALA BIO, Inc. — Director's Dealing 2025
Jun 18, 2025
35091_dirs_2025-06-17_aa305078-6cc6-471c-9e75-7a6eef42c8a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-06-15
Reporting Person: KOVEN ANDREW I (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-15 | Common Stock | A | 3050 | — | Acquired | 16972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-15 | Stock Option (right to buy) | $4.30 | A | 6850 | Acquired | 2035-06-14 | Common Stock (6850) | Direct |
Footnotes
F1: Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.
F2: Includes 8,061 unvested RSUs.
F3: This option was granted on June 15, 2025 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 15, 2026 or (ii) the date of the first annual meeting of stockholders occurring in 2026.